Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors

被引：18
|
作者：
Kolesar, Jill [1 ,2 ]
Huang, Wei [1 ,3 ]
Eickhoff, Jens [1 ,4 ]
Hahn, Kristine [1 ,5 ]
Alberti, Dona [1 ,5 ]
Attia, Steven [1 ,5 ]
Schelman, William [1 ,5 ]
Holen, Kyle [1 ,5 ]
Traynor, Anne [1 ,5 ]
Ivy, Percy [6 ]
Wilding, George [1 ,5 ]
机构：
[1] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI 53792 USA
[2] Univ Wisconsin, Sch Pharm, Madison, WI 53792 USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol, Madison, WI 53792 USA
[4] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat, Madison, WI 53792 USA
[5] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53792 USA
[6] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2009年 / 64卷 / 01期
关键词：
Triapine (R); 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone; Ribonucleotide reductase; Automated quantitative immunohistochemistry (AQUA); Quantitative real time PCR; PHASE-II; CELL-PROLIFERATION; R2; COMPONENT; IN-VITRO; CANCER; OVEREXPRESSION; GEMCITABINE; TRANSFORMATION; RESISTANCE; INCREASES;
D O I：
10.1007/s00280-008-0845-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The purpose of this study was to evaluate baseline RRM2 protein and gene expression in tumors of patients receiving 3-AP. Tumor blocks from patients enrolled in phase I and II clinical studies using 3-AP, were evaluated for RRM2 gene and protein expression by quantitative real time polymerase chain reaction (Q-RTPCR) and automated quantitative analysis (AQUA). Esophageal and gastric cancers overexpressed RRM2 protein when compared to prostate cancer (Z-score, 0.68 +/- A 0.94 SD, vs 0.41 +/- A 0.84 SD, respectively; p = 0.04). Esophageal and gastric cancers also overexpressed RRM2 mRNA when compared to prostate cancer (relative gene expression 2.56 +/- A 1.49 SD, vs 0.29 +/- A 0.20 SD, respectively; p = 0.02). Protein and gene expression were moderately associated (Spearman's rank correlation = 0.30; p = 0.12). RRM2 gene and protein expression varies by tumor type.
引用
收藏
页码：79 / 86
页数：8
相关论文
共 50 条
  • [1] Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors
    Jill Kolesar
    Wei Huang
    Jens Eickhoff
    Kristine Hahn
    Dona Alberti
    Steven Attia
    William Schelman
    Kyle Holen
    Anne Traynor
    Percy Ivy
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 79 - 86
  • [2] EXPRESSION AND POSSIBLE ROLE OF RIBONUCLEOTIDE REDUCTASE SUBUNIT M2 (RRM2) IN ENDOMETRIOSIS
    Jeon, Y. E.
    Lee, Y.
    Jung, J. A.
    Seo, S. K.
    Choi, Y. S.
    Cho, S.
    FERTILITY AND STERILITY, 2012, 98 (03) : S219 - S219
  • [3] Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
    Morikawa, Teppei
    Hino, Rumi
    Uozaki, Hiroshi
    Maeda, Daichi
    Ushiku, Tetsuo
    Shinozaki, Aya
    Sakatani, Takashi
    Fukayama, Masashi
    HUMAN PATHOLOGY, 2010, 41 (12) : 1742 - 1748
  • [4] Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells
    Yang, Pei-Ming
    Lin, Li-Shan
    Liu, Tsang-Pai
    BIOMOLECULES, 2020, 10 (01)
  • [5] Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
    Zuo, Zanwen
    Zhou, Zerong
    Chang, Yuzhou
    Liu, Yan
    Shen, Yuping
    Li, Qizhang
    Zhang, Lei
    GENES & DISEASES, 2024, 11 (01) : 218 - 233
  • [6] Inhibition of Ribonucleotide Reductase Subunit 2 (RRM2) Induces Radiosensitization in Gastroenteropancreatic Neuroendocrine Tumors
    Chow, Z.
    Johnson, J.
    Chauhan, A.
    Izumi, T.
    Cavnar, M.
    Weiss, H.
    Anthony, L.
    Evers, B. M.
    Rychahou, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S160 - S160
  • [7] GENES FOR THE M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE (RRM2) AND FOR RELATED AND CO-AMPLIFIED SEQUENCES LOCALIZED ON HUMAN AND MOUSE CHROMOSOMES
    YANGFENG, TL
    BARTON, DE
    THELANDER, L
    LEWIS, WH
    SRINIVASAN, PR
    FRANCKE, U
    CYTOGENETICS AND CELL GENETICS, 1987, 46 (1-4): : 722 - 722
  • [8] THE ONCOGENIC POTENTIAL OF RIBONUCLEOTIDE REDUCTASE M2 (RRM2) IN CLEAR CELL RENAL CELL CARCINOMA
    Abudawood, Manal
    Ahmed, Nessar
    Wang, Qiuyu
    ANTICANCER RESEARCH, 2014, 34 (10) : 6239 - 6240
  • [9] Targeting ribonucleotide reductase subunit 2 (RRM2) to radio-sensitize glioblastoma
    Corrales-Guerrero, Sergio
    Cui, Tiantian
    Castro-Aceituno, Veronica
    Yang, Linlin
    Feng, Haihua
    Nair, Sindhu
    Shen, Changxian
    Venere, Monica
    Williams, Terence M.
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)
    Xia, Guanggai
    Wang, Hongcheng
    Song, Ziliang
    Meng, Qingcai
    Huang, Xiuyan
    Huang, Xinyu
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36 : 107
12345